Evidence of the neuroprotective role of citicoline in glaucoma patients.

[1]  S. Miglior,et al.  Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. , 2006, Ophthalmology.

[2]  P. Kaufman,et al.  Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma , 2003, Progress in Retinal and Eye Research.

[3]  R. Rejdak,et al.  Oral citicoline treatment improves visual pathway function in glaucoma. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[4]  V. Parisi.  Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s disease , 2003, Seminars in ophthalmology.

[5]  G. Holder,et al.  Relationship between electrophysiological, psychophysical, and anatomical measurements in glaucoma. , 2002, Investigative ophthalmology & visual science.

[6]  J. Jonas,et al.  Monitoring glaucoma progression with visual evoked potentials of the blue-sensitive pathway. , 2002, Investigative ophthalmology & visual science.

[7]  M. Bach,et al.  Electrophysiological Approaches for Early Detection of Glaucoma , 2001, European journal of ophthalmology.

[8]  V. Parisi,et al.  Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients. , 2001, Ophthalmology.

[9]  V. Parisi.  Impaired visual function in glaucoma , 2001, Clinical Neurophysiology.

[10]  A. Liguori,et al.  The protective effect of citicoline on the progression of the perimetric defects in glaucomatous patients (perimetric study with a 10-year follow-up). , 2000, Acta ophthalmologica Scandinavica. Supplement.

[11]  P. Kaufman,et al.  Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. , 2000, Investigative ophthalmology & visual science.

[12]  P. Kaufman,et al.  Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. , 2000, Archives of ophthalmology.

[13]  F Pierelli,et al.  Correlation between morphological and functional retinal impairment in multiple sclerosis patients. , 1999, Investigative ophthalmology & visual science.

[14]  G. Milazzo,et al.  Effects of nicergoline on the retinal and cortical electrophysiological responses in glaucoma patients: a preliminary open study. , 1999, Pharmacological research.

[15]  L. Scullica,et al.  Correlation of pattern electroretinogram with optic disc cup shape in ocular hypertension. , 1999, Investigative ophthalmology & visual science.

[16]  V. Parisi,et al.  Visual function correlates with nerve fiber layer thickness in eyes affected by ocular hypertension. , 1999, Investigative ophthalmology & visual science.

[17]  V. Parisi,et al.  Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. , 1999, Ophthalmology.

[18]  S L Graham,et al.  Early magnocellular loss in glaucoma demonstrated using the pseudorandomly stimulated flash visual evoked potential. , 1999, Journal of glaucoma.

[19]  J. Jonas,et al.  A multivariate sensory model in glaucoma diagnosis. , 1998, Investigative ophthalmology & visual science.

[20]  Robert Ritch,et al.  Visual evoked potential assessment of the effects of glaucoma on visual subsystems , 1998, Vision Research.

[21]  V. Parisi,et al.  Electrophysiological Assessment of Visual Pathways in Glaucoma , 1997, European journal of ophthalmology.

[22]  V. Parisi.  Neural conduction in the visual pathways in ocular hypertension and glaucoma , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.

[23]  N. Swindale,et al.  Comparison of psychophysical and electrophysiological testing in early glaucoma. , 1996, Investigative ophthalmology & visual science.

[24]  L. Fernández-Novoa,et al.  Therapeutic Effects of CDP‐Choline in Alzheimer's Disease‐Cognition, Brain Mapping, Cerebrovascular Hemodynamics, and Immune Factors a , 1996, Annals of the New York Academy of Sciences.

[25]  Vaegan,et al.  Flash and pattern electroretinogram changes with optic atrophy and glaucoma. , 1995, Experimental eye research.

[26]  E. Campos,et al.  Effect of citicoline on visual acuity in amblyopia: preliminary results , 1995, Graefe's Archive for Clinical and Experimental Ophthalmology.

[27]  G. Weiss,et al.  Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. , 1995, Life sciences.

[28]  H Spekreijse,et al.  Recommended standards for electroretinograms and visual evoked potentials. Report of an IFCN committee. , 1993, Electroencephalography and clinical neurophysiology.

[29]  G. Rogers,et al.  Levodopa/carbidopa for childhood amblyopia. , 1993, Investigative ophthalmology & visual science.

[30]  E. Hedley‐Whyte,et al.  Lateral geniculate nucleus in glaucoma. , 1993, American journal of ophthalmology.

[31]  I. Gottlob,et al.  Visual acuities and scotomas after one week levodopa administration in human amblyopia. , 1992, Investigative ophthalmology & visual science.

[32]  V. Parisi,et al.  Visual evoked potentials after photostress in patients with primary open-angle glaucoma and ocular hypertension. , 1992, Investigative ophthalmology & visual science.

[33]  I. Gottlob,et al.  Effect of levodopa on contrast sensitivity and scotomas in human amblyopia. , 1990, Investigative ophthalmology & visual science.

[34]  G. Adams,et al.  The electroretinogram. , 1989, Archives of disease in childhood.

[35]  H. Iijima,et al.  The pattern electroretinogram in glaucoma: an evaluation by relative amplitude from the Bjerrum area. , 1989, The British journal of ophthalmology.

[36]  A. Nagaoka,et al.  Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. , 1988, Stroke.

[37]  G. Moretti,et al.  Pattern electroretinogram as a function of spatial frequency in ocular hypertension and early glaucoma , 1987, Documenta Ophthalmologica.

[38]  Y. Zeevi,et al.  Changes in the oscillatory potentials of the electroretinogram in glaucoma. , 1987, Current eye research.

[39]  D. Kaufman,et al.  Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases. , 1985, Investigative ophthalmology & visual science.

[40]  D. Spinelli,et al.  The ERG in response to alternating gratings in patients with diseases of the peripheral visual pathway. , 1981, Investigative ophthalmology & visual science.

[41]  A. Mistretta,et al.  Effect of CDP-choline on the biosynthesis of nucleic acids and proteins in brain regions during hypoxia , 1981, Neurochemical Research.

[42]  E. P. Kennedy.  The biosynthesis of phospholipids. , 1958, The American journal of clinical nutrition.

[43]  E. P. Kennedy.  Biosynthesis of phospholipides. , 1957, Federation proceedings.

[44]  Lori M. Ventura,et al.  Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study. , 2005, Ophthalmology.

[45]  V. Parisi.  Electrophysiological Assessment of Glaucomatous Visual Dysfunction During Treatment with Cytidine-5′-diphosphocholine (citicoline): A Study of 8 years of Follow-up , 2005, Documenta Ophthalmologica.

[46]  Lori M. Ventura,et al.  Pattern electroretinogram abnormality and glaucoma. , 2005, Ophthalmology.

[47]  I. Gottlob,et al.  Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[48]  G. Grechi,et al.  Therapeutic value of citicoline in the treatment of glaucoma (computerized and automated perimetric investigation) , 2005, International Ophthalmology.

[49]  L. Maffei,et al.  Electroretinographic responses to alternating gratings in the cat , 2004, Experimental Brain Research.

[50]  N. Gupta,et al.  Brain changes in glaucoma. , 2003, European journal of ophthalmology.

[51]  E. Campos,et al.  Cytidine-5'-diphosphocholine improves visual acuity, contrast sensitivity and visually-evoked potentials of amblyopic subjects. , 1998, Current eye research.

[52]  G. Holder.  The pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: A personal clinical review of 743 eyes , 1997, Eye.

[53]  J. Secades,et al.  CDP-choline: pharmacological and clinical review. , 1995, Methods and findings in experimental and clinical pharmacology.

[54]  A. Coppè,et al.  Pattern electroretinogram in treated ocular hypertension: a cross-sectional study after timolol maleate therapy. , 1995, Ophthalmic Research.

[55]  F. Boismare,et al.  Action of cytidine diphosphocholine on functional and hemodynamic effects of cerebral ischemia in cats. , 1978, Pharmacology.